Chief Executive Officer
Henrik Nilsson, MD, PhD (Med. Dr.) joined Forward Pharma in 2006. Read more.
hn@forward-pharma.com

Chief Operating Officer
Mr. Priskorn has a background of more than ten years in late preclinical and early to mid-stage clinical regulatory and development work, including submission of INDs to FDA. Before joining Forward Pharma A/S he held various positions at H. Lundbeck A/S and NeuroSearch A/S. Lundbeck is a public pharmaceutical company, and NeuroSearch is a public biotechnology company, both listed on the Copenhagen Stock Exchange. Mr. Priskorn holds a M. Sc. in pharmacy and a bachelor degree in economics from the Royal Danish School of Pharmacy and Copenhagen Business School, both in Denmark.
mp@forward-pharma.com
